Table 4.
Multivariable Analysis Predicting OS in Stage IV Breast Cancer Patients
| Variable | N | HR (95% CI) | P value |
|---|---|---|---|
| Surgery (yes vs no) | 243 | 0.56 (0.32–0.78) | 0.000 |
| Age (<50 vs ≥50 yr) | 243 | 1.01(0.73–1.33) | 0.812 |
| Bone metastasis | 243 | 0.79 (0.54–1.26) | 0.062 |
| Visceral organ metastasis | 243 | 2.38 (1.37–3.35) | 0.000 |
| Number of metastases(continuous) | 243 | 1.05 (0.72–1.48) | 0.069 |
| ER(+ vs.-) | 243 | 0.54 (0.41–0.85) | 0.000 |
| PR(+ vs.-) | 243 | 0.68 (0.55–0.82) | 0.002 |
| HER2(+ vs.-) | 243 | 1.52 (0.81–1.66) | 0.553 |
Abbreviations: HR, hazard ratio; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor 2.